A randomized phase III study of iniparib (BSI-201) in combination with gemcitabine/carboplatin (G/C) in metastatic triple-negative breast cancer (TNBC) - OʼShaughnessy, J; Schwartzberg, L S; Danso, M A (J Clin Oncol, 2011)
et al.